Aug 20, 2021


Now available on LiverLearning®: Cardiovascular Disease in NASH Patients. Hosted by the Nonalcoholic Fatty Liver Diseases SIG, you will learn about physiological changes of the heart in NAFLD/NASH patients and cardiac outcomes in NAFLD patients (association with disease severity, morbidity and mortality, transplant mortality and post-transplant data). In this webinar, moderated by Mohammad Shadab Siddiqui, MD, and presented by Michelle Long, MD, MSc, Kathleen E. Corey, MD, MPH, MMSc and Leon A. Adams, MBBS, PhD, you will also learn how to include cardiac outcomes in NASH clinical trials.